NettetJonathan Hepple represents Rosetta Capital Ltd. where he is one of the founding Partners. Jonathan has over 17 years of investment experience in the life sciences, … Nettet15. nov. 2024 · In February 2013, Rosetta Capital completed a secondary transaction to acquire a portfolio of thirteen life sciences assets from Karolinska Development, ... Rosetta partners Jonathan Hepple and Ken MacLeod have joined the boards of acquired portfolio companies and are actively involved in strategic decision making.
Mission Therapeutics Welcomes Co-founder of Rosetta Capital, Jonathan ...
NettetJonathan is joining Mission’s Board of Directors following the purchase of Schroder Adveq’s entire holdings in Mission by Rosetta Capital, of which he is co-founder. The … NettetJon Hepple is a co-founder of Rosetta. He has more than 20 years’ investment experience in the life sciences industry. He started his investment career at Rothschild … buona beef chopped salad
Mission Therapeutics Welcomes Co-founder of Rosetta Capital, …
Nettet31. des. 2013 · Jonathan Hepple Ph.D: Co-Founder and Partner: 00: 0: 0: Buckinghamshire, United Kingdom To view Rosetta Capital V’s complete team members history, request access » Rosetta Capital V Returns Data. The below charts are illustrative of the type of graphical data available to our clients and do not represent live data. NettetRosetta is headquartered in the UK and our team is located across Europe and Asia, providing us with broad geographic networks that have proven useful to support our portfolio companies. Jonathan Hepple NettetJonathan Hepple Load 2 more About The Fund Rosetta Capital is a venture capital firm headquartered in Buckinghamshire, United Kingdom. The firm invests in companies operating in the life science and medical technology sectors. The firm has raised five funds to date and specilaizes in acquiring secondary direct portfolios. buona beef caprese sandwich